We have located links that may give you full text access.
Effects of Covid-19 Disease on Retinal and Choroidal Thickness by Optical Coherence Tomography.
Journal of Glaucoma 2023 March 7
PURPOSE: The aim of our study was to evaluate the subclinical changes in the macula, retinal nerve fiber layer (RNFL) and choroidal thickness after COVID-19 infection using spectral domain optical coherence tomography (OCT).
METHODS: Our study was prospectively designed and involved 170 eyes of 85 patients. Patients with PCR positive COVID-19 infection were examined in the ophthalmology clinic before and after infection were included. All included patients had mild COVID-19 with no hospitalization and no need for intubation. Control ophthalmic examination was repeated at least six months after PCR positivity. Macular and choroidal thickness and RNFL parameters were compared before and at least 6 months after PCR positive COVID-19 infection using OCT.
RESULTS: When the mean macular thickness data were evaluated, a significant decrease was detected in the inner (mean difference -3.37 µm; CI95% -6.09 to -0.65, P=0.021) and outer (mean difference -6.56 µm; CI95% -9.26 to -3.86, P<0.001) temporal segments and the inner (mean difference -3.39 µm; CI95% -5.46 to -1.32, P=0.002) and outer (mean difference -2.01 µm; CI95% -3.70 to -0.31, P=0.018) superior segments in the post-COVID-19 measurements compared to pre-COVID-19 measurements. Similarly, on RNFL evaluation, some thinning was evident in the temporal superior (mean=1.14 µm, P=0.004) and temporal inferior (mean=1.30 µm, P=0.032) regions. All choroidal regions, including central, nasal 500 µm and 1500 µm and temporal 500 µm and 1500 µm, exhibited significant thinning (P<0.001).
CONCLUSION: At least six months after mild COVID-19 infection, significant thinning was seen in the temporal and superior quadrants of the macula, the temporal superior and temporal inferior regions of the RNFL and all measured areas of choroidal regions.
METHODS: Our study was prospectively designed and involved 170 eyes of 85 patients. Patients with PCR positive COVID-19 infection were examined in the ophthalmology clinic before and after infection were included. All included patients had mild COVID-19 with no hospitalization and no need for intubation. Control ophthalmic examination was repeated at least six months after PCR positivity. Macular and choroidal thickness and RNFL parameters were compared before and at least 6 months after PCR positive COVID-19 infection using OCT.
RESULTS: When the mean macular thickness data were evaluated, a significant decrease was detected in the inner (mean difference -3.37 µm; CI95% -6.09 to -0.65, P=0.021) and outer (mean difference -6.56 µm; CI95% -9.26 to -3.86, P<0.001) temporal segments and the inner (mean difference -3.39 µm; CI95% -5.46 to -1.32, P=0.002) and outer (mean difference -2.01 µm; CI95% -3.70 to -0.31, P=0.018) superior segments in the post-COVID-19 measurements compared to pre-COVID-19 measurements. Similarly, on RNFL evaluation, some thinning was evident in the temporal superior (mean=1.14 µm, P=0.004) and temporal inferior (mean=1.30 µm, P=0.032) regions. All choroidal regions, including central, nasal 500 µm and 1500 µm and temporal 500 µm and 1500 µm, exhibited significant thinning (P<0.001).
CONCLUSION: At least six months after mild COVID-19 infection, significant thinning was seen in the temporal and superior quadrants of the macula, the temporal superior and temporal inferior regions of the RNFL and all measured areas of choroidal regions.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app